NovaBiotics to Present New Data at 42nd European Cystic Fibrosis Conference

Category: Events

27

NovaBiotics set to present new data on the antimicrobial mechanism of action, mucolytic mechanism of action and recent clinical data for our oral and inhaled Cystic Fibrosis drug candidates, Lynovex at the 42nd European Cystic Fibrosis Conference being held in Liverpool on 5-8 June 2019.